Plan B-One Step, the so-called “morning after pill,” won’t be made available over the counter to girls younger than 17, regardless of a previous Food and Drug Administration recommendation, according to a statement by U.S. Department of Health & Human Services Secretary Kathleen Sebelius.
In a surprise move, Sebelius invoked her authority as the agency’s head to overrule the recommendation of the FDA’s Center for Drug Evaluation and Research — and the conclusions drawn by FDA Commissioner Margaret Hamburg, according to statements issued today.
The move drew swift condemnation from reproductive health activists:
“We are outraged that this administration has let politics trump science,” said Kirsten Moore, president and CEO of the Reproductive Health Technologies Project in Washington, D.C. “There is no rationale for this move. This is unprecedented, as evidenced by the commissioner’s own letter.”